Phenylbutazone and sulfinpyrazone interaction with oral anticoagulant phenprocoumon.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Archives of Internal Medicine

• Publication date

  1982-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHINTE.1982.00340220048010PMID 7114982
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stereoselective Interaction of Sulfinpyrazone with Racemic Warfarin and Its Separated Enantiomorphs in Man

  1982cited by this paper
• Comparative interaction of sulfinpyrazone and phenylbutazone with racemic warfarin: alteration in vivo of free fraction of plasma warfarin.

  1981cited by this paper
• Stereochemical aspects of the metabolism of phenprocoumon in rat liver microsomes.

  1981cited by this paper
• [The effect of sulfinpyrazone on the coagulation-inhibiting action of acenocoumarol].

  1981cited by this paper
• Effect of induction and inhibition of drug metabolism on pharmacokinetics and anticoagulant activity of the enantiomers of phenprocoumon in rats.

  1980cited by this paper
• Comparative pharmacokinetics of coumarin anticoagulants XLV: Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin and phenylbutazone in rats.

  1980cited by this paper
• Potentiation of warfarin action by sulphinpyrazone.

  1980cited by this paper
• Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man.

  1980cited by this paper
• Interaction of phenylbutazone with racemic phenprocoumon and its enantiomers in rats

  1979cited by this paper
• The effect of bezafibrate on the fibrinolytic enzyme system and the drug interaction with racemic phenprocoumon.

  1978cited by this paper
• Interaction of allopurinol with phenprocoumon in man

  1977cited by this paper
• [Elimination kinetics of phenprocoumon (Marcumar) in liver cirrhosis and after premedication with phenobarbital].

  1976cited by this paper
• DRUG ENHANCEMENT OF WARFARIN ACTIVITY

  1975cited by this paper
• Letter: Drug enhancement of warfarin activity.

  1975cited by this paper
• Interaction of sodium warfarin and disulfiram (antabuse) in man.

  1973cited by this paper
• Studies on the Interaction of Warfarin and Clofibrate in Man

  1972cited by this paper
• Studies on the interaction of warfarin and clofibrate in man.

  1972cited by this paper
• Properties of 3-(1-Phenyl-Propyl)-4-Oxycoumarin (Marcoumar®) in the Plasma when Tested in Normal Cases and under the Influence of Drugs

  1968cited by this paper
• COMBINED EFFECT OF SODIUM WARFARIN AND PHENYLBUTAZONE.

  1964cited by this paper
• Information and error : an introduction to statistical analysis

  1959cited by this paper

• Comparative Pharmacokinetics of Vitamin K Antagonists

  2005cites this paper
• The effects of frusemide and probenecid on the pharmacokinetics of phenprocoumon

  2004cites this paper
• Clinically Important Drug Interactions with Anticoagulants

  1996cites this paper
• Anticoagulants in Older Patients

  1995cites this paper
• Medikamentöse Beeinflussung der Harnsäureausscheidung

  1990cites this paper
• Phenylbutazone-hydroxycoumarol interactions. Effects on steady state disposition, hepatocellular distribution, and biliary excretion of (S)-acenocoumarol in rats.

  1988cites this paper
• The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans

  1987cites this paper
• Identification of phenprocoumon metabolites in human urine by high-performance liquid chromatography and gas chromatography-mass spectrometry.

  1985cites this paper
• Metabolic fate of phenprocoumon in humans.

  1985cites this paper
• Update of cardiovascular drug interactions.

  1985cites this paper
• Effect of nonsteroidal anti-inflammatory drugs on the microsomal monooxygenase system of rat liver.

  1985cites this paper
• Drugs affecting blood clotting and hemostasis

  1984cites this paper
• Comparative interaction of cimetidine and ranitidine with racemic warfarin in man.

  1984cites this paper